59 Recruiting Crohn's Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Crohn's Disease
Related Conditions
Top Recruiting Crohn's Disease Studies
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
📍 Univ Alabama, Birmingham CCC /ID# 146060 — Birmingham, Alabama
View Study & Checklist ➔A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
📍 University of Alabama Liver Center — Birmingham, Alabama
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
📍 Gi Alliance - Arizona Digestive Health - Sun City /ID# 268178 — Sun City, Arizona
View Study & Checklist ➔Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
📍 Blacktown Hospital /ID# 258574 — Blacktown, New South Wales
View Study & Checklist ➔Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
📍 Center for Colitis and Crohns Disease University of California — San Francisco, California
View Study & Checklist ➔Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
📍 Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884 — Mesa, Arizona
View Study & Checklist ➔A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
📍 Clinical Research Facility — Mobile, Alabama
View Study & Checklist ➔VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
📍 GI Alliance - Sun City — Sun City, Arizona
View Study & Checklist ➔A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
View Study & Checklist ➔OTIS Cimzia Pregnancy Registry
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
📍 East View Medical Research, LLC /ID# 171132 — Mobile, Alabama
View Study & Checklist ➔An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
📍 Universitaetsklinikum St. Poelten /ID# 258828 — Sankt Pölten, Lower Austria
View Study & Checklist ➔A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
📍 Arizona Arthritis & Rheumatology Research, PLLC — Phoenix, Arizona
View Study & Checklist ➔Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
📍 Montefiore Medical Center — The Bronx, New York
View Study & Checklist ➔Online Pain Education for Crohn's Disease and Ulcerative Colitis
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
📍 Medical Research Center of Connecticut — Hamden, Connecticut
View Study & Checklist ➔MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease
📍 Washington University in St. Louis — Louis, Missouri
View Study & Checklist ➔68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
📍 Digestive Health Specialists /ID# 266216 — Dothan, Alabama
View Study & Checklist ➔A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
📍 Investigational Site Number: 8400024 — Tucson, Arizona
View Study & Checklist ➔A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
📍 GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400020 — Sun City, Arizona
View Study & Checklist ➔A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
📍 UCSD Medical Center — La Jolla, California
View Study & Checklist ➔A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
📍 Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039 — Colorado Springs, Colorado
View Study & Checklist ➔Behavioral Therapy for Crohn's Disease
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
📍 UCSF Benioff Children's Hospital - Oakland /ID# 262217 — Oakland, California
View Study & Checklist ➔A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
📍 Digestive Health Specialists /ID# 280827 — Dothan, Alabama
View Study & Checklist ➔A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Phoenix Children's Hospital /ID# 255766 — Phoenix, Arizona
View Study & Checklist ➔Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔Helmsley 3.0: Abbreviated MRE
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Beta-Hydroxybutyrate Feasibility Treating IBD
📍 University of Texas at Austin — Austin, Texas
View Study & Checklist ➔A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
📍 Mayo Clinic Florida — Jacksonville, Florida
View Study & Checklist ➔A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
📍 United Medical Doctors — Murrieta, California
View Study & Checklist ➔Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔